Asia Pacific Biofilms Treatment Market to Grow at a CAGR of 8.3% to reach US$ 512.60Million from 2020 to 2027

Asia Pacific Biofilms Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Debridement Equipment, Gauzes and Dressings, Grafts and Matrices, and Others); Wound (Traumatic and Surgical Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Others); End User (Hospitals, Home Care Settings, and Others); and Country

  • Report Code : TIPRE00018176
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 141
Buy Now

The Asia Pacific biofilms treatment market is expected to reach US$ 512.60 million in 2027 from US$271.40 million in 2019. The market is estimated to grow with a CAGR of 8.3% from 2020-2027.

Biofilms are composed of mixed strains of fungi, bacteria, yeasts, algae, and other microbes. A biofilm develops on the wound surface when certain types of bacteria or fungi adhere to the wound surface and form a matrix over it. A viscous and shiny substance with unpleasant smell are secreted. Growing number of traumatic, sports injuries, coupled with increasing prevalence of obesity are anticipated to drive the market growth during the forecast period. The scope of the biofilms treatment market includes product, wound, end-user, and region.

India Biofilms Treatment Market Revenue and Forecasts to 2027 (US$ MN)

ASIA PACIFICBIOFILMS TREATMENT MARKET SEGMENTATION

By Product

  • Gauzes and Dressings
  • Debridement Equipment
  • Grafts and Matrices
  • Others

 By Wound

  • Traumatic and Surgical Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Others

By End User

  • Hospitals
  • Home Care Settings
  • Others

By Country

  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific

Company Profiles

  • Smith & Nephew
  • MiMedx
  • ConvaTec Group Plc
  • Coloplast Group
  • Mölnlycke Health Care AB.
  • Organogenesis Inc.
  • Integra Life Sciences Corporation
  • B. Braun Melsungen AG
  • Hartman Group
  • Medline Industries, Inc.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Wound, End User, and Country

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Australia, China, Japan, South Korea

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 BiofilmsTreatment DevicesMarket – By Product

1.3.2 BiofilmsTreatment DevicesMarket – By Wound

1.3.3 BiofilmsTreatment DevicesMarket – By End User

1.3.4 Asia Pacific Biofilms Treatment Devices Market – By Country

2. Asia Pacific Biofilms Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia PacificBiofilms Treatment Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Biofilms Treatment Market- Asia Pacific PEST Analysis

4.3 Expert Opinion

5. Asia PacificBiofilms Treatment Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Rapid Technological Advancements and New Market Players

5.1.2 Increasing Incidences of Diabetic Foot Ulcers due to Rising Cases of Diabetes

5.2 Market Restraints

5.2.1 Antibiotic-Drug Resistance Issue Associated with Biofilms Treatment

5.3 Market Opportunities

5.3.1 A surge in Number of Geriatric Population

5.4 Future Trends

5.4.1 Increasing Research and Development in the Biofilms Treatment Market

5.5 Impact Analysis

6. Biofilms Treatment Market – Asia Pacific Analysis

6.1 Asia Pacific Biofilms Treatment Market Revenue Forecasts and Analysis

7. Asia Pacific Biofilms Treatment Market Analysis and Forecasts To 2027 – By Product

7.1 Overview

7.2 Biofilms Treatment Market Revenue Share, by Product (2019 and 2027)

7.3 Debridement Equipment

7.3.1 Overview

7.3.2 Debridement Equipment: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

7.4 Gauzes and Dressings

7.4.1 Overview

7.4.2 Gauzes and Dressings: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

7.5 Grafts and Matrices

7.5.1 Overview

7.5.2 Grafts and Matrices: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

8. Asia Pacific Biofilms Treatment Market Analysis – By Wound

8.1 Overview

8.2 Biofilms Treatment Market Revenue Share, by Wound (2019 and 2027)

8.3 Traumatic and Surgical Wounds

8.3.1 Overview

8.3.2 Traumatic and Surgical Wounds: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Diabetic Foot Ulcers

8.4.1 Overview

8.4.2 Diabetic Foot Ulcers: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

8.5 Pressure Ulcers

8.5.1 Overview

8.5.2 Pressure Ulcers: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

8.6 Venous Leg Ulcers

8.6.1 Overview

8.6.2 Venous Leg Ulcers: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

9. Asia Pacific Biofilms Treatment Market Analysis – By End-User

9.1 Overview

9.2 Biofilms Treatment Market Share, by End User, 2019 and 2027, (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Home Care Settings

9.4.1 Overview

9.4.2 Home Care Settings: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

10. Biofilms Treatment Market Revenue and Forecasts To 2027 – Geographical Analysis

10.1 Asia Pacific: Biofilms Treatment Market

10.1.1 Overview

10.1.2 Asia Pacific: Biofilms Treatment Market – Revenue and Forecast to 2027 (USD Millions)

10.1.3 Asia Pacific: Biofilms Treatment Market, by Product, 2018-2027 (USD Millions)

10.1.4 Asia Pacific: Biofilms Treatment Market, by Wound, 2018-2027 (USD Millions)

10.1.5 Asia Pacific: Biofilms Treatment Market, by End User, 2018-2027 (USD Millions)

10.1.6 Asia Pacific: Biofilms Treatment Market, by Country, 2019 & 2027 (%)

10.1.7 China: Biofilms Treatment Market

10.1.7.1 China: Biofilms Treatment Market – Revenue and Forecast to 2027 (USD Millions)

10.1.7.1.1 China: Biofilms Treatment Market, by Product, 2018-2027 (USD Millions)

10.1.7.1.2 China: Biofilms Treatment Market, by Wound, 2018-2027 (USD Millions)

10.1.7.1.3 China: Biofilms Treatment Market, by End User, 2018-2027 (USD Millions)

10.1.8 Japan: Biofilms Treatment Market

10.1.8.1 Japan: Biofilms Treatment Market – Revenue and Forecast to 2027 (USD Millions)

10.1.8.1.1 Japan: Biofilms Treatment Market, by Product, 2018-2027 (USD Millions)

10.1.8.1.2 Japan: Biofilms Treatment Market, by Wound, 2018-2027 (USD Millions)

10.1.8.1.3 Japan: Biofilms Treatment Market, by End User, 2018-2027 (USD Millions)

10.1.9 India: Biofilms Treatment Market

10.1.9.1 India: Biofilms Treatment Market – Revenue and Forecast to 2027 (USD Millions)

10.1.9.1.1 India: Biofilms Treatment Market, by Product, 2018-2027 (USD Millions)

10.1.9.1.2 India: Biofilms Treatment Market, by Wound, 2018-2027 (USD Millions)

10.1.9.1.3 India: Biofilms Treatment Market, by End User, 2018-2027 (USD Millions)

10.1.10 South Korea: Biofilms Treatment Market

10.1.10.1 South Korea: Biofilms Treatment Market – Revenue and Forecast to 2027 (USD Millions)

10.1.10.1.1 South Korea: Biofilms Treatment Market, by Product, 2018-2027 (USD Millions)

10.1.10.1.2 South Korea: Biofilms Treatment Market, by Wound, 2018-2027 (USD Millions)

10.1.10.1.3 South Korea: Biofilms Treatment Market, by End User, 2018-2027 (USD Millions)

10.1.11 Australia: Biofilms Treatment Market

10.1.11.1 Australia: Biofilms Treatment Market – Revenue and Forecast to 2027 (USD Millions)

10.1.11.1.1 Australia: Biofilms Treatment Market, by Product, 2018-2027 (USD Millions)

10.1.11.1.2 Australia: Biofilms Treatment Market, by Wound, 2018-2027 (USD Millions)

10.1.11.1.3 Australia: Biofilms Treatment Market, by End User, 2018-2027 (USD Millions)

11. Impact Of COVID-19 Pandemic on Asia PacificBiofilms Treatment Market

11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

12.1 ConvaTec Group Plc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Coloplast Group

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 B. Braun Melsungen AG

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

13. Appendix

13.1 About the Insight Partners

13.2 Glossary of terms

LIST OF TABLES

Table 1. Asia Pacific Biofilms Treatment Market, by Product – Revenue and Forecast to 2027 (USD Millions)

Table 2. Asia Pacific Biofilms Treatment Market, by Wound – Revenue and Forecast to 2027 (USD Millions)

Table 3. Asia Pacific Biofilms Treatment Market, by End User – Revenue and Forecast to 2027 (USD Millions)

Table 4. China Biofilms Treatment Market, by Product – Revenue and Forecast to 2027 (USD Millions)

Table 5. China Biofilms Treatment Market, by Wound – Revenue and Forecast to 2027 (USD Millions)

Table 6. China Biofilms Treatment Market, by End User – Revenue and Forecast to 2027 (USD Millions)

Table 7. Japan Biofilms Treatment Market, by Product – Revenue and Forecast to 2027 (USD Millions)

Table 8. Japan Biofilms Treatment Market, by Wound – Revenue and Forecast to 2027 (USD Millions)

Table 9. Japan Biofilms Treatment Market, by End User – Revenue and Forecast to 2027 (USD Millions)

Table 10. India Biofilms Treatment Market, by Product – Revenue and Forecast to 2027 (USD Millions)

Table 11. India Biofilms Treatment Market, by Wound – Revenue and Forecast to 2027 (USD Millions)

Table 12. India Biofilms Treatment Market, by End User – Revenue and Forecast to 2027 (USD Millions)

Table 13. South Korea Biofilms Treatment Market, by Product – Revenue and Forecast to 2027 (USD Millions)

Table 14. South Korea Biofilms Treatment Market, by Wound – Revenue and Forecast to 2027 (USD Millions)

Table 15. South Korea Biofilms Treatment Market, by End User – Revenue and Forecast to 2027 (USD Millions)

Table 16. Australia Biofilms Treatment Market, by Product – Revenue and Forecast to 2027 (USD Millions)

Table 17. Australia Biofilms Treatment Market, by Wound – Revenue and Forecast to 2027 (USD Millions)

Table 18. Australia Biofilms Treatment Market, by End User – Revenue and Forecast to 2027 (USD Millions)

Table 19. Glossary of Terms,Biofilms Treatment Market

LIST OF FIGURES

Figure 1. Biofilms Treatment Market Segmentation

Figure 2. Asia PacificBiofilms Treatment Market Overview

Figure 3. Gauzes and DressingsSegment Held Largest Share of Product inBiofilms TreatmentMarket

Figure 4. India is Expected to Show Remarkable Growth During the Forecast Period

Figure 5. Biofilms Treatment Market - Asia Pacific PEST Analysis

Figure 6. Biofilms Treatment Market Impact Analysis of Driver and Restraints

Figure 7. Asia PacificBiofilms Treatment Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 8. Biofilms Treatment Market Revenue Share, by Product (2019 and 2027)

Figure 9. Debridement Equipment: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Figure 10. Gauzes and Dressings: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11. Grafts and Matrices: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12. Others: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13. Biofilms Treatment Market Revenue Share, by Wound (2019 and 2027)

Figure 14. Traumatic and Surgical Wounds: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15. Diabetic Foot Ulcers: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16. Pressure Ulcers: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17. Venous Leg Ulcers: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18. Others: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19. Biofilms Treatment Market Share, by End User, 2019 and 2027 (%)

Figure 20. Hospitals: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21. Home Care Settings: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22. Others: Biofilms Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23. Asia Pacific: Biofilms Treatment Market, by Key Country – Revenue (2019) (USD Millions)

Figure 24. Asia Pacific Biofilms Treatment Market Revenue and Forecast to 2027 (USD Millions)

Figure 25. Asia Pacific: Biofilms Treatment Market, by Country, 2019 & 2027 (%)

Figure 26. China Biofilms Treatment Market Revenue and Forecast to 2027 (USD Millions)

Figure 27. Japan Biofilms Treatment Market Revenue and Forecast to 2027 (USD Millions)

Figure 28. India Biofilms Treatment Market Revenue and Forecast to 2027 (USD Millions)

Figure 29. South Korea Biofilms Treatment Market Revenue and Forecast to 2027 (USD Millions)

Figure 30. Australia Biofilms Treatment Market Revenue and Forecast to 2027 (USD Millions)

Figure 31. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

  1. Smith & Nephew
  2. MiMedx
  3. ConvaTec Group Plc
  4. Coloplast Group
  5. Mölnlycke Health Care AB.
  6. Organogenesis Inc.
  7. Integra Life Sciences Corporation
  8. B. Braun Melsungen AG
  9. Hartman Group
  10. Medline Industries, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Asia Pacific Biofilms Treatment Market